HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuhiko Kuwahara Selected Research

Lymphangioma (Cavernous Lymphangioma)

10/2006Production of two novel monoclonal antibodies that distinguish mouse lymphatic and blood vascular endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuhiko Kuwahara Research Topics

Disease

8Neoplasms (Cancer)
02/2024 - 08/2011
4Breast Neoplasms (Breast Cancer)
01/2021 - 12/2013
3Cholangiocarcinoma
10/2013 - 08/2009
2Carcinogenesis
10/2020 - 04/2016
2Infections
01/2020 - 01/2016
2Polyploidy
11/2010 - 10/2004
2Inflammation (Inflammations)
08/2009 - 04/2004
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
04/2023
1Teratoma (Teratoid Tumor)
04/2023
1Myocarditis (Carditis)
12/2022
1COVID-19
12/2022
1Genomic Instability
10/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2020
1Virus Diseases (Viral Diseases)
01/2016
1Lung Neoplasms (Lung Cancer)
08/2013
1Adenocarcinoma of Lung
08/2013
1Necrosis
07/2012
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2010
1Astrocytoma (Pilocytic Astrocytoma)
11/2009
1Glioblastoma (Glioblastoma Multiforme)
11/2009
1Chromosomal Instability (Chromosome Stability)
11/2009
1Glioma (Gliomas)
11/2009
1HIV Infections (HIV Infection)
01/2009
1Plasmacytoma
03/2008
1Lymphangioma (Cavernous Lymphangioma)
10/2006

Drug/Important Bio-Agent (IBA)

8Nuclear Proteins (Protein, Nuclear)IBA
02/2024 - 08/2009
5Messenger RNA (mRNA)IBA
12/2022 - 11/2009
5Proteins (Proteins, Gene)FDA Link
10/2020 - 04/2004
4DNA (Deoxyribonucleic Acid)IBA
12/2013 - 10/2004
3EpitopesIBA
01/2020 - 10/2013
3Small Interfering RNA (siRNA)IBA
12/2013 - 11/2010
2AntibodiesIBA
01/2016 - 10/2006
2Complementary DNA (cDNA)IBA
12/2013 - 04/2004
2CarbohydratesIBA
10/2013 - 08/2011
2ErbB Receptors (EGF Receptor)IBA
08/2013 - 11/2009
1COVID-19 VaccinesIBA
12/2022
1Propidium (Propidium Iodide)IBA
01/2021
1Conditioned Culture MediaIBA
02/2019
1Interleukin-10 (Interleukin 10)IBA
02/2019
1Interleukin-6 (Interleukin 6)IBA
02/2019
1CytokinesIBA
02/2019
1Cre recombinaseIBA
04/2016
1Estrogens (Estrogen)FDA Link
04/2016
1Peptides (Polypeptides)IBA
01/2016
1VaccinesIBA
01/2016
1Glycoproteins (Glycoprotein)IBA
01/2016
1RNA (Ribonucleic Acid)IBA
12/2013
1S 27IBA
10/2013
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
08/2013
1Tyrosine Kinase InhibitorsIBA
08/2013
1Gefitinib (Iressa)FDA Link
08/2013
1Therapeutic UsesIBA
08/2013
1Pharmacologic ActionsIBA
08/2013
1CaspasesIBA
07/2012
1AntigensIBA
08/2011
1Mucin 5ACIBA
08/2011
1Interleukin-2 Receptors (IL 2 Receptor)IBA
12/2010
1Cytidine DeaminaseIBA
08/2009
1Immunoglobulin Variable RegionIBA
08/2009
1Monoclonal AntibodiesIBA
01/2009
1SyndecansIBA
03/2008
1Collagenases (Collagenase)FDA Link
10/2006
1Neuraminidase (Sialidase)IBA
10/2006

Therapy/Procedure

3Therapeutics
04/2023 - 08/2013
1Drug Therapy (Chemotherapy)
02/2024
1Transplantation
04/2023